Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Remy Cointreau's shares rise as investors bet on recovery



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Remy Cointreau's shares rise as investors bet on recovery</title></head><body>

Updates shares in paragraphs 1 & 9, CEO quotes in paragraph 6, adds investor comment in paragraphs 11-12

LONDON, June 6 (Reuters) -Remy Cointreau's RCOP.PA shares rose more than 6% on Thursday after the drinks company expressed confidence about future growth following a tough year where profits fell sharply.

The maker of Remy Martin cognac and Cointreau liquor faced difficulties throughout the year in the United States and China, which make up the vast majority of cognac sales.

A tough economy dragged in China while elevated inventories in the United States weighed as sales came down from a post-COVID boom.

The company said a recovery was anticipated only from the second half, but it signalled confidence in future growth.

Progress towards its long-term targets, including high single-digit annual sales growth, will resume from 2025-26, it said.

Chief Executive Officer Eric Vallat said the company was taking a variety of measures to restore U.S. sales and the group's growth, and looking to build up sales elsewhere in the world including Europe, Nigeria, South Africa and India.

Remy's annual organic operating profit fell by 27.8% in the year ending March 31, but this was smaller than the 28.2% decline predicted by analysts.

The sharp profit fall came alongside a drop in sales, which were down 19.2% organically.

Remy's shares pared initial gains to stand 3.9% higher by 0842 GMT, but the stock remained among the top gainers in Europe's STOXX 600 index .STOXX and on track for their best day in a month.

The company's shares had hit their lowest since 2020 a day earlier, and closed down almost 30% on the start of the year.


U.S. TROUBLES

James Squire, a portfolio manager at Remy investor River Global, said the market was starting to buy into a Remy recovery after poor sentiment drove declines in the share price in recent months.

"The time to buy these stocks is when everyone else is worried," he continued, adding Remy's valuation would likely improve.

In the short-term, Remy continues to face difficulties in the United States.

The company said it had reduced staff in its U.S. division by 10% alongside other measures to improve performance.

Vallat told journalists Remy would continue to resist cutting prices or discounting. But it would pursue an "optimisation" of pricing by U.S. state for its cheaper category of cognac, hardest hit by the decline, he said.

Remy's profit beat was helped by 145 million euros ($157.82 million) in cost savings, exceeding its target of 100 million euros.

Its board would propose a 2 euro per share dividend, Remy said.




Reporting by Emma Rumney; Editing by Janane Venkatraman, Michael Perry and Jane Merriman

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.